{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:30:06Z","timestamp":1792884606712,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaci.2025.02.008","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T12:27:02Z","timestamp":1739881622000},"page":"1898-1912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-1425","authenticated-orcid":false,"given":"Jaehwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-1778","authenticated-orcid":false,"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.02.008_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJMe2314345","article-title":"Psoriasis\u2014more progress but more questions","volume":"390","author":"Gelfand","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005115","article-title":"The imbalance between type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris","volume":"13","author":"Kim","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","article-title":"Highly effective new treatments for psoriasis target the IL-23\/type 17 T cell autoimmune axis","volume":"68","author":"Kim","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(19)31773-8","article-title":"Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial","volume":"394","author":"Reich","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.02.008_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjd.19341","article-title":"Efficacy and safety of risankizumab vs secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial","volume":"184","author":"Warren","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","article-title":"Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis","volume":"376","author":"Papp","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib8","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","article-title":"Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic vs regulatory immune cell subsets","volume":"148","author":"Kim","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib9","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/s41467-023-39484-4","article-title":"Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis","volume":"14","author":"Fries","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.02.008_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1250504","article-title":"Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin","volume":"14","author":"Kim","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaad.2022.04.060","article-title":"Secukinumab improves mild-to-moderate psoriasis: a randomized, placebo-controlled exploratory clinical trial","volume":"88","author":"Kim","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.008_bib13","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1073\/pnas.0906988106","article-title":"IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells","volume":"106","author":"Guo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.008_bib14","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1073\/pnas.0705268104","article-title":"IL-6\u2013dependent and \u2013independent pathways in the development of interleukin 17\u2013producing T helper cells","volume":"104","author":"Kimura","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.008_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imm.12938","article-title":"The role of transforming growth factor \u03b2 in T helper 17 differentiation","volume":"155","author":"Zhang","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2025.02.008_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib17","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.4049\/jimmunol.181.9.5948","article-title":"IL-23 promotes maintenance but not commitment to the Th17 lineage","volume":"181","author":"Stritesky","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib18","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","article-title":"Cutting edge: the pathogenicity of IFN-\u03b3\u2013producing Th17 cells is independent of T-bet","volume":"190","author":"Duhen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-\u03b3 or IL-10 and are regulated by IL-1\u03b2","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.02.008_bib20","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","article-title":"Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites","volume":"20","author":"Kumar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2025.02.008_bib21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjd.17748","article-title":"CD 8 resident memory T cells with interleukin 17A\u2013producing potential are accumulated in disease-na\u00efve nonlesional sites of psoriasis possibly in correlation with disease duration","volume":"181","author":"Vo","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib22","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib23","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jid.2021.03.011","article-title":"PD-1 expression defines epidermal CD8+CD103+ T cells preferentially producing IL-17A and using skewed TCR repertoire in psoriasis","volume":"141","author":"Phadungsaksawasdi","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib24","article-title":"Defining patient-level molecular heterogeneity in psoriasis vulgaris based on single-cell transcriptomics","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib25","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jaci.2018.11.042","article-title":"Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab","volume":"143","author":"Visvanathan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1468-3083.2009.03292.x","article-title":"Immunopathogenesis of psoriasis: focus on natural killer T cells","volume":"23","author":"Peternel","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2025.02.008_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-002-0349-4","article-title":"Natural killer and natural killer\u2013T cells in psoriasis","volume":"294","author":"Cameron","year":"2002","journal-title":"Arch Derm Res"},{"key":"10.1016\/j.jaci.2025.02.008_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5858\/2003-127-0289-RORIIN","article-title":"Reactivity of resident immunocytes in normal and prepsoriatic skin using an ex vivo skin-explant model system","volume":"127","author":"Curry","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib29","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/eji.200940257","article-title":"CD161 is a marker of all human IL-17\u2013producing T-cell subsets and is induced by RORC","volume":"40","author":"Maggi","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib30","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17\u2013producing cells originate from a CD161+CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.12688\/f1000research.6116.1","article-title":"Defining the functional states of Th17 cells","volume":"4","author":"Lee","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.jaci.2025.02.008_bib32","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.jaci.2020.11.028","article-title":"Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer","volume":"147","author":"Liu","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl9165","article-title":"Classification of human chronic inflammatory skin disease based on single-cell immune profiling","volume":"7","author":"Liu","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imlet.2020.11.005","article-title":"Increased peripheral helper T cells type 17 subset correlates with the severity of psoriasis vulgaris","volume":"229","author":"Liu","year":"2021","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2025.02.008_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08114","article-title":"The AP-1 transcription factor Batf controls TH17 differentiation","volume":"460","author":"Schraml","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.02.008_bib36","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109803","article-title":"Batf stabilizes Th17 cell development via impaired Stat5 recruitment of Ets1-Runx1 complexes","volume":"42","author":"Pham","year":"2023","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2025.02.008_bib37","doi-asserted-by":"crossref","first-page":"8700","DOI":"10.1158\/0008-5472.CAN-09-1145","article-title":"Interleukin 12 stimulates IFN-gamma\u2013mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance","volume":"69","author":"Cao","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2025.02.008_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4049\/jimmunol.181.1.721","article-title":"In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12\/IL-23 balance and promotes differentiation of Th17 cells","volume":"181","author":"Khayrullina","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib39","article-title":"Reprogramming of IL-12 secretion in the PDCD1 locus improves the anti-tumor activity of NY-ESO-1 TCR\u2013T cells","volume":"14","author":"Kim","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/mi.2008.84","article-title":"The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut","volume":"2","author":"Wang","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib41","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fimmu.2018.01112","article-title":"Insight into non-pathogenic Th17 cells in autoimmune diseases","volume":"9","author":"Wu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib42","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib43","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-017-01571-8","article-title":"Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.02.008_bib44","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.4049\/jimmunol.0900123","article-title":"c-Maf regulates IL-10 expression during Th17 polarization","volume":"182","author":"Xu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib45","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2025.02.008_bib46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4049\/jimmunol.1102216","article-title":"IL-13 regulates Th17 secretion of IL-17A in an IL-10\u2013dependent manner","volume":"188","author":"Newcomb","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib47","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.4049\/jimmunol.0803868","article-title":"A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production","volume":"182","author":"Newcomb","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib48","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaci.2010.11.043","article-title":"Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production","volume":"127","author":"Newcomb","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib49","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/mi.2017.5","article-title":"TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine","volume":"10","author":"Pascual-Reguant","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2025.02.008_bib51","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202345","article-title":"Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis","volume":"218","author":"Nakamizo","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202249816","article-title":"Guidelines for mouse and human DC generation","volume":"53","author":"Lutz","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12865-020-00394-5","article-title":"The role of \u03b22 integrin in dendritic cell migration during infection","volume":"22","author":"Altorki","year":"2021","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib54","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1073\/pnas.151028698","article-title":"A role for CD36 in the regulation of dendritic cell function","volume":"98","author":"Urban","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.008_bib55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.02.008_bib56","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jaci.2015.09.055","article-title":"The tryptophan metabolism enzyme l-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases","volume":"137","author":"Harden","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib57","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4049\/jimmunol.1502615","article-title":"Tolerogenic phenotype of IFN-\u03b3\u2013induced IDO+ dendritic cells is maintained via an autocrine IDO-kynurenine\/AhR-IDO loop","volume":"197","author":"Li","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib59","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jaci.2023.05.012","article-title":"Single-cell transcriptomics suggest distinct upstream drivers of IL-17A\/F in hidradenitis versus psoriasis","volume":"152","author":"Kim","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib60","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1084\/jem.20112583","article-title":"Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation","volume":"209","author":"Chu","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11273","article-title":"Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity","volume":"7","author":"Uto","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.02.008_bib62","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood-2007-05-089771","article-title":"The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells","volume":"111","author":"Young","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.02.008_bib63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/BS9.0000000000000109","article-title":"LILRB4, an immune checkpoint on myeloid cells","volume":"4","author":"Yang","year":"2022","journal-title":"Blood Sci"},{"key":"10.1016\/j.jaci.2025.02.008_bib64","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3389\/fimmu.2019.03146","article-title":"DNGR-1, a dendritic cell\u2013specific sensor of tissue damage that dually modulates immunity and inflammation","volume":"10","author":"Cueto","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib65","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.jaci.2017.08.012","article-title":"TNF-\u03b1\u2013induced protein 3 levels in lung dendritic cells instruct TH2 or TH17 cell differentiation in eosinophilic or neutrophilic asthma","volume":"141","author":"Vroman","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib66","doi-asserted-by":"crossref","first-page":"12705","DOI":"10.1073\/pnas.230436397","article-title":"Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages","volume":"97","author":"Sanjabi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.02.008_bib67","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.153.2.712","article-title":"NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site","volume":"153","author":"Cogswell","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib68","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri3313","article-title":"A20: linking a complex regulator of ubiquitylation to immunity and human disease","volume":"12","author":"Ma","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.immuni.2011.05.013","article-title":"The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity","volume":"35","author":"Kool","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.02.008_bib70","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1600-0625.2011.01323.x","article-title":"Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis","volume":"20","author":"Riis","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib71","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/eji.201545917","article-title":"Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation","volume":"46","author":"Wang","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib72","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI44478","article-title":"Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells","volume":"121","author":"Garza","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.02.008_bib73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature11984","article-title":"Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1","volume":"496","author":"Wu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.02.008_bib75","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.20082584","article-title":"T-bet is essential for encephalitogenicity of both Th1 and Th17 cells","volume":"206","author":"Yang","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib76","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10228","article-title":"Control of TH17 cells occurs in the small intestine","volume":"475","author":"Esplugues","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.02.008_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib78","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.cell.2019.01.041","article-title":"Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans","volume":"176","author":"Bacher","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2025.02.008_bib79","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13555-021-00511-1","article-title":"Comparative efficacy and relative ranking of biologics and oral therapies for moderate-to-severe plaque psoriasis: a network meta-analysis","volume":"11","author":"Armstrong","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2025.02.008_bib80","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.02.008_bib81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jamadermatol.2020.0723","article-title":"Efficacy and safety of continuous risankizumab therapy vs treatment withdrawal in patients with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial","volume":"156","author":"Blauvelt","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib82","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","article-title":"Guselkumab (an IL-23\u2013specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis","volume":"133","author":"Sofen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib83","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2015.01.018","article-title":"Anti\u2013IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial","volume":"136","author":"Krueger","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100297","article-title":"Differential pharmacodynamic effects on psoriatic biomarkers by guselkumab versus secukinumab correlate with long-term efficacy: an ECLIPSE substudy","volume":"4","author":"Blauvelt","year":"2024","journal-title":"JID Innov"},{"key":"10.1016\/j.jaci.2025.02.008_bib85","article-title":"A single-cell transcriptional gradient in human cutaneous memory T cells restricts Th17\/Tc17 identity","volume":"3","author":"Cook","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi2848","article-title":"A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response","volume":"9","author":"Wu","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib87","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jid.2021.01.005","article-title":"Differential changes in inflammatory mononuclear phagocyte and T-cell profiles within psoriatic skin during treatment with guselkumab vs secukinumab","volume":"141","author":"Mehta","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.02.008_bib88","article-title":"Risk of candidiasis associated with interleukin-17 inhibitors: a real-world observational study of multiple independent sources","volume":"13","author":"Davidson","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jaci.2025.02.008_bib89","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus secukinumab in plaque psoriasis","volume":"385","author":"Reich","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.02.008_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaci.2025.02.008_bib91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2025.02.008_bib92","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41467-024-44994-w","article-title":"Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade","volume":"15","author":"Francis","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.02.008_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.02.008_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100125","article-title":"Revisiting the experimental methods for human skin T-cell analysis","volume":"2","author":"Sato","year":"2022","journal-title":"JID Innov"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:27:32Z","timestamp":1777696052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0091674925001757"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.02.008","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}